Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06311461 · ClinicalTrials.gov registry record · NA

Effects of Acupuncture on Symptoms of Stable Angina

A NA study of Angina, Stable, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT06311461: Recruiting NA study of Angina, Stable, sponsored by University of California, Los Angeles.

NCT06311461 is a NA study of Angina, Stable that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 112 participants, below the 269-participant average among 4 other Angina, Stable trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06311461, a NA study of Angina, Stable, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine if a standardized 12-point acupuncture protocol will reduce pain in participants with stable angina. This study addresses the critical need to reduce persistent pain for angina. The investigators long-term goal is symptom management for diverse women and men with angina, targeting additional angina burden borne of social disadvantage Participants will be randomized to a 10-acupuncture session protocol, two treatments per week for five weeks, or an attention control group. Participants will view designated, non-pain related Technology, Entertainment, Design Talks equal to the time spent receiving acupuncture (\~7.5-10 hrs.). The investigators will test the efficacy of acupuncture for stable angina/chest pain syndrome to reduce pain and symptoms, improve health-related quality of life, reduce healthcare utilization and and improve patient related health outcomes.

Primary Outcome

numeric rating scale 0-10, 0=no pain and 10=worst pain imaginable right now

Conditions Studied

Interventions

  • PROCEDURE Acupuncture
  • OTHER Attention control

Study Locations (1)

California

  • UCLA School of Nursing - Los Angeles

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2024-04-01
Est. Completion 2027-06-30
Phase NA

What NCT06311461 shows while recruiting

NCT06311461 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 269-participant average among 4 other Angina, Stable trials with a reported enrollment target (58% lower).

The record links to 1 condition, with Angina, Stable appearing as the primary indexed condition, and to 2 interventions - of which Acupuncture is the first listed.

NCT06311461 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06311461 about?

NCT06311461 is a clinical study titled "Effects of Acupuncture on Symptoms of Stable Angina". The goal of this clinical trial is to determine if a standardized 12-point acupuncture protocol will reduce pain in participants with stable angina. This study addresses the critical need to reduce persistent pain for angina. The investigators long-term goal is symptom management for diverse women ...

What is the current status of trial NCT06311461?

This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2024-04-01. Estimated completion is 2027-06-30.

What conditions does trial NCT06311461 study?

This clinical trial studies the following conditions: Angina, Stable.

What interventions are being tested in trial NCT06311461?

The interventions under investigation include: Acupuncture (PROCEDURE), Attention control (OTHER).

Who is sponsoring clinical trial NCT06311461?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06311461 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Angina, Stable

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06311461, the US trial registry maintained by the National Library of Medicine. NCT06311461 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.